Healthcare Workers Have More Frequent and Less Severe Influenza-Like Illness Than Non-healthcare Workers: Findings From the PAIVED Study
Ryan Liberg(Madigan Army Medical Center), Stephanie A Richard(Henry M. Jackson Foundation), Bruce McClenathan(Womack Army Medical Center), Tahaniyat Lalani(Henry M. Jackson Foundation), Christina Schofield(Madigan Army Medical Center), Adam K. Saperstein(Uniformed Services University of the Health Sciences), Laurie A. Housel(Womack Army Medical Center), Simon D. Pollett(Henry M. Jackson Foundation), Alan L. Williams(Walter Reed National Military Medical Center), David Hrncir(Wilford Hall Ambulatory Surgical Center), Rhonda E Colombo(Henry M. Jackson Foundation), A. Ganesan(Henry M. Jackson Foundation), Ana E Markelz(Uniformed Services University of the Health Sciences), Srihari Seshadri(Defense Health Agency), Ryan C. Maves(Naval Medical Center San Diego), Timothy Burgess, Christian Coles(Henry M. Jackson Foundation), CDR M Simons(Henry M. Jackson Foundation), John H Powers(Frederick National Laboratory for Cancer Research), Katrin Mende(Henry M. Jackson Foundation), Jitendrakumar R Modi(Naval Facilities Engineering Systems Command), Christina Spooner(Defense Health Agency), Wesley Campbell(Walter Reed National Military Medical Center), Catherine M Berjohn(Naval Medical Center San Diego), Kat Schmidt(Henry M. Jackson Foundation), Robert J O’Connell(Uniformed Services University of the Health Sciences), Tyler Warkentien(Walter Reed National Military Medical Center)
Cited by 1
Related Papers
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Cohort Study of Molecular Identification and Typing of <i>Mycobacterium abscessus, Mycobacterium massiliense</i> , and <i>Mycobacterium bolletii</i>
|Journal of Clinical Microbiology|2009|221
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure
|Clinical Infectious Diseases|2019|110
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
|Science Translational Medicine|2022|94